Coca-Cola takes on Olipop and Poppi with new prebiotic soda brand, Simply Pop

The U.S. prebiotic soda category has more than doubled over the last five years.

High-cost sickle cell gene therapies push insurers and Medicaid programs to find new payment models

The high cost of sickle cell gene therapies is pushing private insurers and Medicaid programs to develop new payment models.

Nike’s decision to partner with Skims comes as it looks to claw back market share and return to growth under new CEO Elliott Hill.